Business
Macquarie trims CSL’s price target and outlook – The Australian Financial Review
As new COVID-19 cases surge in the US unemployment benefits and travel restrictions on Mexican citizens are limiting plasma collection….
Macquarie analysts estimated that foot traffic for about 100 of CSLs US-based plasma collection centres has remained subdued following a step-down in June, leading the investment bank to reduce its fiscal 2022 immunoglobulin volume growth assumptions.
Macquarie…
Continue Reading
-
Noosa News12 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General21 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
General22 hours agoRed tape on chopping block in bid to build homes faster
-
Noosa News24 hours agoGirl charged with attempted murder after foster carer stabbed in Ipswich